Detail of the clinical trial

Title of the trial A Phase II Open Label Study of Sargramostim Among Patients Receiving Myelosuppressive Induction Chemotherapy for Acute Myelogenous Leukemia
EudraCT number 2015-000479-28
Protocol number LTS13932
Sponsor Genzyme Corporation, 500 Kendall Street, 02142 Cambridge, MA, United States of America
Indications Hemato-oncology
Diagnosis acute myeloid leukemia
Population in clinical trial Adults (18-65 years)
Elderly ( > 65 years)
Male
Female
Patients
Year of receiving the request to Institute (SÚKL) 2015
Date of approval by Institute (SÚKL) 3.8.2015
Date of approval by EC 17.8.2015
Date of initiation CT in ČR
Date of ending CT in ČR
Notice
Sites Fakultní nemocnice Ostrava, Klinika hematoonkologie, 17. listopadu 1790, 708 52 Ostrava
Fakultní nemocnice Hradec Králové, IV. interní hematologická klinika, Sokolská 581, 500 05 Hradec Králové

‹‹ Back to list